Inhibitory effect of complement inactivation and epigallocatechin gallate on the human serum ability to induce cutaneous neovascular reaction in mice

Bulletin of the Veterinary Institute in Pulawy

Volumn 48, Issue 4, 2004, Pages 485-487

  Skopiński, Piotr ^a,b   Skopińska Rózewska, Ewa ^c   Sommer, Ewa ^c   Chorostowska Wynimko, Joanna ^c   Demkow, Urszula ^c   Rogala, Ewa ^c   Filewska, Małgorzata ^c  

^a Biostructure Centre   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Angiogenesis; Complement; Cytokines; Epigallocatechin gallate; Human serum; Mouse

Indexed keywords

EPIGALLOCATECHIN GALLATE; INTERLEUKIN 18; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; EVALUATION; HEATING; HUMAN; MOUSE; NONHUMAN;

EID: 15744373424     PISSN: 00424870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barcz E., Skopińska-Różewska E., Kamiński P., Demkow U., Bobrowska K., Marianowski L.: Angiogenic ativity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. Int J Gynecol Obstet 2002, 79, 229-235.
2. Cao Y., Cao R., Brakenhielm E.: Antiangiogenic mechanism of diet-derived polyphenols. J Nutr Biochem 2002, 13, 380-390.
3. Feng X., Tonnesen M.G., Peerschke E.I., Ghebrehiwet B.: Cooperation of C1q reception and integrins in C1q mediated endothelial cell adhesion and spreading. J Immunol 2002, 168, 2441-2448.
4. Hakansson L., Venge P.: The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber. Scand J Immunol 1984, 19, 63-73.
5. Hollosy F., Meszaros G., Bokonoi G., Idei M., Seprodi A., Szende B., Keri G.: Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumors cells. Anticancer Res 2000, 20, 4563-4570.
6. Kim M.H.: Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem 2003, 89, 529-538.
7. Kondo T., Ohta T., Igura K., Hara Y., Kaji K.: Tea catechins inhibit angiogenesis in vitro, mesured by endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Letters 2002, 180, 139-144.
8. Lamy S., Gingras D., Beliveau R.: Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002, 62, 381-385.
9. Langeggen H., Berge K.E., Johnson E., Hetland G.: Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro. Inflammation 2002, 26, 103-10.
10. Langeggen H., Johnson E., Hetland G.: Effects of C5a and FMLP on interleukin-8 production and proliferation and proliferation of human umbilical vein endothelial cells. Inflammation 2001, 25, 83-89.
11. Laudes I.J., Chu J.C., Huber-Lang M., Guo R.F., Riedemann N.C., Sarma J.V., Mahdi F., Murphy H.S., Speyer C., Lu K.T., Lambris J.D., Zetoune F.S., Ward P.A.: Expression and function of C5a receptor in mouse microvascular endothelial cells. J Immunol 2002, 169, 5962-5970.
12. Rogala E., Skopińska-Różewska E., Załȩ ska J., Borowska A., Demkow U., Skopiński P., Dziedzic D., Langfort R., Orłowski T.: Angiogenic activity and angiotensin-converting enzyme levels in sera of lung cancer patients. Onkol Pol 2002, 5, 139-142.
13. Schraufstatter I.U., Trieu K., Sikora L., Sriramarao P., DiScipio R.: Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol 2002, 169, 2102-2110.
14. Sidky Y.A., Auerbach R.: Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of graft-vs-host reaction. J Exp Med 1975, 141, 1084.
15. Singh A.K., Seth P., Husain M.M., Madhavan S., Mukhtar H., Maheshwari R.K.: Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Arch Biochem Biophys 2002, 401, 29-37.
16. Solvik U.O., Haraldsen G., Fiane A.E., Boretti E., Lambris J.D., Fung M., Thorsby E., Mollnes T.E.: Human serum-induced expression of E-selection on porcine aortic endothelial cells in vitro is totally complement mediated. Transplantation 2001, 72, 1967-1973.
17. Xiao S., Xu C., Jarvis J.N.: C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC. Clin Exp Immunol 2001, 125, 360-367.